FRESH-PEF73382-en
National cohort on imprinting disorders and their metabolic consequences
RaDiCo-IDMet
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data','Behavioral data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Endocrinology | health theme |
| Neurology | health theme |
| Paediatrics | health theme |
| Psychiatry | health theme |
| Overgrowth syndromes | cim-11 |
| Prader-Willi syndrome | cim-11 |
| Angelman syndrome | cim-11 |
| Syndromes with multiple structural anomalies, not of environmental origin | cim-11 |
| Pseudohypoparathyroidism | cim-11 |
| Transient neonatal diabetes mellitus | cim-11 |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Infant, Newborn (birth to 28 days)","concept":{"vocab":"MeSH","vocabURI":"D007231"}},{"value":"Infant (28 days to 2 years)","concept":{"vocab":"MeSH","vocabURI":"D007223"}},{"value":"Child, Preschool (2 to 5 years)","concept":{"vocab":"MeSH","vocabURI":"D002675"}},{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}},{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patients (adults and children) affected with an ID regardless of the severity of the disease, - with a confirmed diagnosis of ID (based on molecular diagnosis) - with a signed informed consent for adults or signed informed consent of parents/guardians of minors/protected adult. ","clusion_E":"There are no non-inclusion criteria."}
| Name |
|---|
| Irène;NETCHINE |
| Agnès;LINGLART |
| Name | Role |
|---|---|
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | sponsor |
| Name |
|---|
| AGENCE NATIONALE DE LA RECHERCHE (ANR) |
| Name |
|---|
| Rare diseases health networks FIRENDO and OSCAR / ENDO - European Reference Network (ERN) |
| Agency name |
|---|
| CNIL |
| CPP |
| CESREES |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2017-01-01 | 2032-01-01 |
| Standard |
|---|
| ['Drug dictionary (DCIs)'] |
['Data Management Plan and Data Validation Plan. Continuous data management (automatic control rules and query system)']
Access requests to RaDiCo-IDMet data (rough / structured), biocollections or to analytic reports will be examined by the scientific committee following submission of a Specific Research Project (SRP) synopsis, as defined in the Resource Access Charter. Must be sent to idmet@radico.fr
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}